Sunday, December 7, 2025

Latest

Cresco Labs Finalizes Acquisition of Hope Heal Health

Cresco Labs (CSE:CL), has received change in ownership approval from the Massachusetts Cannabis Control Commission, and has thus finalized the acquisition of Hope Heal Health Inc.

Currently, Hope Heal Health owns a facility and dispensary in Fall River Massachusetts, and is fully functioning as a cannabis cultivator and manufacturer. The company also holds several state licenses, including a retail license, manufacturing license, as well as a cultivation license. Hope Heal Health also has the ability to procure two additional retail licenses in Massachusetts

In addition, Hope Heal Health has also recently been granted a recreational cannabis license for its dispensary, meaning that following the acquisition, the company can still sell cannabis to medical-use patients, but will also be catering to adult-use customers through Cresco’s several cannabis brands.

Now that the acquisition is complete, Cresco plans to distribute its branded products in the Massachusetts adult-use cannabis market. The company owns several brands, including Remedi, Cresco, and Mindy’s Edibles.

Cresco Labs is a United States based cannabis operator, and is currently trading at $7.31 on the CSE.


Information for this briefing was found via Sedar and Cresco Labs. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Guanajuato Silver: Q3 Results Overshadowed By Silver Ripping

I Went to See the Highest Grade Silver on Earth | Nord Precious Metals

DPM Metals: Discovery To Feasibility In 36 Months!

Recommended

Emerita Resources Awards Contract For Pre-Feasibility Study On Iberian Belt West Project

Selkirk Copper Appoints Two Members Of Selkirk First Nation To Leadership Team

Related News

US Cannabis: The Current Landscape

Welcome to the Deep Dive Video Essay Series. Today we are looking at US Cannabis....

Saturday, March 6, 2021, 09:00:00 AM

Cresco Labs: Stifel Slashes Price Target From $30 To $8 Following Poor Q4 Results

On March 23rd, Cresco Labs (CSE: CL) announced its fourth-quarter financial results, which disappointed many...

Friday, March 25, 2022, 03:39:00 PM

Cresco Labs Receives Court Approval To Proceed With Columbia Care Acquisition

Cresco Labs (CSE: CL) is inching closer to finalizing its previously announced acquisition of Columbia...

Friday, July 15, 2022, 08:09:23 AM

Cresco Labs: Canaccord Bumps Price Target Up To $20.50

Wednesday, Canaccord came out with their updated valuations for the large three multi-state operators. With...

Sunday, January 17, 2021, 01:41:00 PM

Cresco Labs Lowers Q4 2021 Revenue Guidance After Reducing Third Party Agreements

Cresco Labs (CSE: CL) announced on Thursday that it is exiting exclusive distributorship agreements of certain...

Friday, October 1, 2021, 09:22:00 AM